As shown in Figure 9, expression of EPO from KiSAS cells is equivalent to that observed from primary renal cell populations currently under development for cell therapy of anemias secondary to CKD [35], suggesting that kidney sourced adipose may represent an alternate cell source for cellular vectors for EPO delivery. This evidence concerns the gene EPO and anemia.